Compare up to 4 stocks side by side, across all 7 of StockIQ's scoring categories.
| Category | PASG Passage Bio, Inc. | AAPG Ascentage Pharma Group International - American Depository |
|---|---|---|
| Price | $4.80 -0.0% | $14.86 -2.5% |
| StockIQ Score | 52C- Moderate Risk: High | 36F Weak Risk: Medium |
| Technical | 48D+ | 13F |
| Fundamental | 46D+ | 35F |
| Growth | 66B- | 50C- |
| Fair Value | 55C | 38F |
| News | 50C- | 50C- |
| Quality | — | 50C- |
| Risk | 40D | 48D+ |
Scores are based on real financial data only and do not constitute investment advice. How the score is calculated
Passage Bio (PASG) outperforms Ascentage Pharma (AAPG) in nearly every category. Its investor score (55 vs. 37) and technical score (59 vs. 18) are significantly higher, showing stronger market confidence and technical strength. Growth score (66 vs. 50) also favors PASG, while AAPG’s weak rating and lower fundamental score (35 vs. 46) highlight its weaker overall standing. Valuation scores are tied at 55.
